Containment of neuroimmune challenge by diosgenin confers amelioration of neurochemical and neurotrophic dysfunctions in ketamine-induced schizophrenia in mice
Open Access
- 9 February 2024
- journal article
- research article
- Published by Elsevier in Brain Disorders
- Vol. 13, 100122
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Myeloperoxidase-Derived Oxidants Induce Blood-Brain Barrier Dysfunction In Vitro and In VivoPLOS ONE, 2013
- Characterization of ADME Properties of Diosgenin and Dioscin: Bioactive Constituents of Dioscorea villosa (Wild yam)Planta Medica, 2013
- Convergent Findings for Abnormalities of the NF-κB Signaling Pathway in SchizophreniaNeuropsychopharmacology, 2012
- Neurochemical and molecular characterization of ketamine-induced experimental psychosis model in miceNeuropharmacology, 2012
- Acute toxicity and sub-chronic toxicity of steroidal saponins from Dioscorea zingiberensis C.H.Wright in rodentsJournal of Ethnopharmacology, 2009
- Diosgenin targets Akt‐mediated prosurvival signaling in human breast cancer cellsInternational Journal of Cancer, 2009
- IL-6 Mediated Degeneration of Forebrain GABAergic Interneurons and Cognitive Impairment in Aged Mice through Activation of Neuronal NADPH OxidasePLOS ONE, 2009
- Driving fast-spiking cells induces gamma rhythm and controls sensory responsesNature, 2009
- Ketamine-Induced Loss of Phenotype of Fast-Spiking Interneurons Is Mediated by NADPH-OxidaseScience, 2007
- Effectiveness, Safety, and Tolerability of Risperidone in Adolescents with Schizophrenia: An Open-Label StudyJournal of Child and Adolescent Psychopharmacology, 2003